Showing results (601-610 of 816) with videos related to

Sort By:
Pageof 82
Experimental Hematology|November 1, 1981
Allogeneic bone marrow transplantation for chronic granulocytic leukemiaK C Doney, C D Buckner, E D Thomas, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1984
Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionationH J Deeg, N Flournoy, K M Sullivan, et al.
Experimental Hematology|January 1, 1983
Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemiaM S Tsoi, R P Warren, R Storb, et al.
Clinical Genetics|October 1, 1990
Bone marrow transplantation in canine GM1 gangliosidosisJ S O'Brien, R Storb, R F Raff, et al.
Blood|December 1, 1986
Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factorsH J Deeg, S Self, R Storb, et al.
Blood|September 25, 1999
Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplantR Storb, C Yu, J M Zaucha, et al.
Blood|September 1, 1982
Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host diseaseK Atkinson, V Farewell, R Storb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphomaC Hosing, M Munsell, S Yazji, et al.
Bone Marrow Transplantation|June 27, 2006
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemiaP Kebriaei, R M Saliba, C Ma, et al.
Transplantation|November 1, 1992
Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibodyC Anasetti, P J Martin, R Storb, et al.
Pageof 82